News

A majority of executives believe technology has become an inseparable part of the human experience in a recent survey. However, a bit more than half of those execs said advancements in new technologies and scientific innovations are positioned to disrupt the industry.

Excess deaths associated with the two pandemics are in the same ballpark during New York City peaks.

Dr. Karen Vloedman shares her learnings that will help inform best practices to assist payers and provider groups when preparing for and navigating the CoVID-19 pandemic.

In this week's episode, Briana Contreras spoke with Suzet McKinney, CEO of the Illinois Medical District and an Adjunct Instructor at Harvard University's T.H. Chan School of Public Health. The two discussed the role of social determinants when promoting health and health equity and most importantly why and how racism is a public health issue.

Harris ended up proposing a moderate Medicare for all plan modeled on the Medicare Advantage choice that seniors now have.

Physical therapy or the regular physical activity that successful treatment of MSK disorders makes possible helps reduce the risk of many chronic conditions including type 2 diabetes, heart disease and hypertension, dementia, and mental health issues like depression and anxiety.

Colcrys and Copaxone are among the exceptions.

Evrysdi is only the second drug approved to treat the rare disease.

Botco.ai’s AI-powered intelligent chat solution automatically addresses questions regarding COVID-19, scheduling visits, franchising and more.

Researchers reviewed the evidence of the association between vitamin D and multiple sclerosis.

A recent study found 64% of patients with psoriatic arthritis who had tried at least one biologic stayed with Cosentyx for the entire study period.

Next generation PBMs like Flipt and RxSense are challenging the "old guard" PBMs that control three-quarters of the market.

Adaptive Biotechnologies’ clonoSEQ gets third approval; FDA also acts on first at-home treatment for spinal muscular atrophy.

In this part two of two video series Adam Block discusses his recent article, “Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates.”

Dovato lets adults with HIV reduce the number of antiretroviral therapies they take, while maintaining efficacy and a high barrier to resistance comparable to tenofovir-based regimens.

In this part one of two video series, Adam Block, a New York Medical College assistant professor, discusses his recent contributed article to Managed Healthcare Executive titled "Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates."

Double-blind study will compare Rebif-remdesivir combination with remdesivir-alone in hospitalized COVID-19 patients

The highly respected healthcare industry veteran will bring his signature team building skills, track record of double-digit revenue growth and subject matter expertise in diabetes.

In this part two of two series, Carolyn Langer, M.D., Fallon Health's chief medical officer, talks about Collective Medical and the advantages of real-time notifications of member hospital admissions and discharges and emergency department visits.

This week on Tuning Into The C-Suite, Managed Healthcare Executive Senior Editor Peter Wehrwein speaks with Assistant Professor of Public Health at New York Medical College, Adam Block. The two discuss Block's recent article published in MHE, "Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates" and more.

Amid struggling providers, furloughs of essential workers, years of premium increases and record high earnings, for-profit health plans should consider options for directly helping their networks.

Research model shows that caps on out-of-pocket costs don't result in higher health plan spending.

In this part one of two series, Carolyn Langer, M.D., the chief medical officer, says the Massachusetts health plan mounted a big push on telehealth that includes in-person visit payment levels.

The American College of Cardiology issues its second set of recommendations for its members on prescribing two groups of drugs first developed for type 2 diabetes.

It's early days yet because patent and other issues have kept FDA-approved biosimilars off the market, but Gary Lyman, M.D., M.P.H.. of the Fred Hutchinson Cancer Research Center says there's evidence of some effect on the price of cancer supportive drugs.

The chimeric antigen receptor (CAR) T cell therapy is the first of its kind for mantle cell lymphoma (MCL).

Many are anxious or down but finding silver linings amidst challenges; essential workers and boomers are faring better than most.